Fluor® 488 Anti-Human CD38 Antibody[HIT2]
Cat No.: FCE1970
Size：
| Product Name: | Fluor® 488 Anti-Human CD38 Antibody[HIT2] |
| Cat No.: | FCE1970 |
| host: | Mouse |
| uniprot id: | P28907 |
| geneid: | 952 |
| application: | FCM |
| isotype: | Mouse IgG1, κ |
| form: | Liquid |
| storage: | This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
| shipping: | Ice bag |
| category id: | Flow Cytometry Antibodies |
| abbreviation: | CD38 |
| conjugation: | Fluor® 488 |
| species reactivity: | Human |
| usage: | Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
| clone no.: | HIT2 |
| background: | CD38 is a 45 kD type II transmembrane glycoprotein also known as T10. It is an ADP-ribosyl hydrolase expressed at variable levels on hematopoietic cells and in some non-hematopoietic tissues (such as brain, muscles, and kidney). In humans, it is expressed at high levels on plasma cells and activated T and B cells. By functioning as both a cyclase and a hydrolase, CD38 mediates lymphocyte activation, adhesion, and the metabolism of cADPR and NAADP. CD31 is the ligand of CD38. |
| target synonym: | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1;CD38;2---phospho-ADP-ribosyl cyclase;2---phospho-cyclic-ADP-ribose transferase;ADP-ribosyl cyclase 1;ADPRC 1;Cyclic ADP-ribose hydrolase 1;cADPr hydrolase 1;T10;CD38; |
| concentration: | 5 μL/Test |
| buffer: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
| image 1 description: | Human peripheral blood lymphocytes are stained with Fluor® 488 Anti-Human CD38 Antibody (filled gray histogram). Unstained lymphocytes (empty black histogram) are used as control. |